Upgrade to SI Premium - Free Trial

Surgery Partners (SGRY) PT Lowered to $17 at TD Cowen

May 8, 2026 8:23 AM
TD Cowen analyst Ryan Langston lowered the price target on Surgery Partners (NASDAQ: SGRY) to $17.00 (from $20.00) while maintaining a Buy rating.

Categories

Analyst PT Change